EUVIMEDEUVIMED entdecken
VergleichsstudieOpen Access · CC BY-NC 4.0

Third-Trimester Screening for Preeclampsia in Twins: Comparative Performance of Fetal Medicine Foundation Algorithm, Roche, and Quidel Triages

Adeline Walter, Annegret Geipel, Corinna Simonini, Brigitte Strizek, Adi Sharabi-Nov, Nadav Kugler, Ran Svirsky, Jacob Segal, Marina Mor-Shalom, Lea Valinsky, Shaden Naser, Ramzia Abu Hamed und 3 weitere

Fetal Diagnosis and Therapy · 2025

DOI: 10.1159/000546981 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Fetal Diagnosis and Therapy, 2025. Verfasst von Adeline Walter und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Prenatal Medicine, University Hospital Bonn, Bonn, Germany. Hauptthemen laut MEDLINE: Pre-Eclampsia, Pregnancy Trimester, Third, Algorithms, Pregnancy, Twin. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

We aimed to compare three preeclampsia screening methods in the third trimester: (a) Fetal Medicine Foundation (FMF) multi-marker algorithm (maternal factors, biophysical markers, serum placental growth factor [PlGF], and soluble fms-like tyrosine kinase-1 [sFLT-1]); (b) Roche triage (sFLT-1/PlGF), on fresh and stored samples; and (c) Quidel triage (PlGF) on stored samples.

Methods

Women with two live fetuses were enrolled at a twin clinic at 11–13 weeks’ gestation. They visited the clinic every 2–4 weeks until delivery for examination. Blood testing was conducted at enrollment in the first trimester at 11–13 weeks’ gestation, and at 20–22 and 32–34 weeks’ gestations. Here we evaluated the screening characteristics in the third trimester and the detection rate (DR), false-positive rate (FPR), and positive and negative predictive values (PPV and NPV) and compared the screening efficacy based on recommended cutoffs and area under the receiver operation characteristic curve (AUROC).

Results

Third-trimester analysis included 146 women with twin pregnancies, of which 24 (16.4%) had preeclampsia. Preeclampsia prediction was conducted by three methods. (1) A prospective prediction was conducted on fresh samples using the FMF algorithm risk assessment in the third trimester for twin pregnancies, which had a DR of 79.2% and a FPR of 5.3%, with PPV and NPV of 76.0% and 95.5%, respectively. (2) Roche triage was tested on fresh samples prospectively using soluble fms-like tyrosine kinase-1 (sFLT-1) versus placental growth factor (PlGF), with a cutoff ratio >38, had a DR of 62.5% and a FPR of 22.1%, with PPV and NPV of 37.5% and 90.7%, respectively. In addition, we repeated the testing with Roche’s Triage using stored samples and the same sFLT-1/PlGF ratio>38. (3) Quidel triage was performed retrospectively using stored samples, acting according to the definition of high risk according to PlGF

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pre-EclampsiaPregnancy Trimester, ThirdAlgorithmsPregnancy, TwinPrenatal DiagnosisHumansFemalePregnancyAdultPlacenta Growth FactorBiomarkersVascular Endothelial Growth Factor Receptor-1Triage

Stichwörter der Autor:innen

Competing risk modelPlacental growth factorPreeclampsia predictionQuidel triageRoche triageScreening efficacySoluble fms-like tyrosine kinaseTwin pregnancysFLT-1/PlGF ratio

Substanzen

Placenta Growth FactorBiomarkersVascular Endothelial Growth Factor Receptor-1PGF protein, humanFLT1 protein, human

Autor:innen und Institutionen

  • Department of Obstetrics and Prenatal Medicine, University Hospital Bonn, Bonn, Germany.
  • BMBF Bundesministerium für Bildung und Forschung, DLR Deutsches Zentrum für Luft- und Raumfahrt, Cologne, Germany.
  • Department of Statistics, Tel Hai Academic College, Tel Hai, Israel.
  • Ziv Medical Center, Safed, Israel.
  • Department of Obstetrics and Gynecology, Shamir (Assaf Harofeh) Medical Center, Tzrifin, Israel.
  • Medical Genetic Unit, Department of Obstetrics and Gynecology, Samson Assuta Ashdod University Hospital, Ashdod, Israel.

Zitieren

APA

Walter, A., Geipel, A., Simonini, C., Strizek, B., Sharabi-Nov, A., Kugler, N., Svirsky, R., Segal, J., Mor-Shalom, M., Valinsky, L., Naser, S., Abu Hamed, R., Meiri, H., Maymon, R., & Cuckle, H. (2025). Third-Trimester Screening for Preeclampsia in Twins: Comparative Performance of Fetal Medicine Foundation Algorithm, Roche, and Quidel Triages. Fetal Diagnosis and Therapy. https://doi.org/10.1159/000546981

Vancouver

Walter A, Geipel A, Simonini C, Strizek B, Sharabi-Nov A, Kugler N, et al. Third-Trimester Screening for Preeclampsia in Twins: Comparative Performance of Fetal Medicine Foundation Algorithm, Roche, and Quidel Triages. Fetal Diagnosis and Therapy. 2025. doi:10.1159/000546981

BibTeX
@article{Walter2025,
  author = {Walter, Adeline and Geipel, Annegret and Simonini, Corinna and Strizek, Brigitte and Sharabi-Nov, Adi and Kugler, Nadav and Svirsky, Ran and Segal, Jacob and Mor-Shalom, Marina and Valinsky, Lea and Naser, Shaden and Abu Hamed, Ramzia and Meiri, Hamutal and Maymon, Ron and Cuckle, Howard},
  title = {Third-Trimester Screening for Preeclampsia in Twins: Comparative Performance of Fetal Medicine Foundation Algorithm, Roche, and Quidel Triages},
  journal = {Fetal Diagnosis and Therapy},
  year = {2025},
  doi = {10.1159/000546981}
}
Kostenlos starten →